- Home
- EXEL vs FNF Comparison
EXEL vs FNF Comparison
Compare EXEL & FNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | FNF |
|---|---|---|
| Founded | 1994 | 1847 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 13.7B |
| IPO Year | 2000 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EXEL | FNF |
|---|---|---|
| Price | $70.52 | $42.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $59.79 | $52.25 |
| AVG Volume (30 Days) | ★ 2.3M | 2.2M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.13% |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.46 | 1.98 |
| Revenue | $452,477,000.00 | ★ $14,445,000,000.00 |
| Revenue This Year | $10.16 | $1.75 |
| Revenue Next Year | $12.43 | $1.28 |
| P/E Ratio | $28.34 | ★ $20.46 |
| Revenue Growth | N/A | ★ 5.58 |
| 52 Week Low | $37.58 | $37.88 |
| 52 Week High | $72.10 | $60.37 |
Technical Indicators
Market Signals| Indicator | EXEL | FNF |
|---|---|---|
| Relative Strength Index (RSI) | 83.32 | 58.95 |
| Support Level | $54.85 | $37.88 |
| Resistance Level | N/A | $42.12 |
| Average True Range (ATR) | 1.80 | 1.02 |
| MACD | 0.59 | 0.36 |
| Stochastic Oscillator | 87.36 | 98.48 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. All of the company's revenue is generated in the United States.